Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
editorial
. 1991 Apr;67(786):323–326. doi: 10.1136/pgmj.67.786.323

Fluoride treatment in osteoporosis.

P Pitt, H Berry
PMCID: PMC2398812  PMID: 2068022

Full text

PDF
323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beary D. F. The effects of fluoride and low calcium on the physical properties of the rat femur. Anat Rec. 1969 Jul;164(3):305–316. doi: 10.1002/ar.1091640306. [DOI] [PubMed] [Google Scholar]
  2. Budden F. H., Bayley T. A., Harrison J. E., Josse R. G., Murray T. M., Sturtridge W. C., Kandel R., Vieth R., Strauss A. L., Goodwin S. The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention. J Bone Miner Res. 1988 Apr;3(2):127–132. doi: 10.1002/jbmr.5650030202. [DOI] [PubMed] [Google Scholar]
  3. Dambacher M. A., Ittner J., Ruegsegger P. Long-term fluoride therapy of postmenopausal osteoporosis. Bone. 1986;7(3):199–205. doi: 10.1016/8756-3282(86)90018-9. [DOI] [PubMed] [Google Scholar]
  4. Dandona P., Gill D. S., Khokher M. A. Fluoride and osteoblasts. Lancet. 1989 Feb 25;1(8635):449–450. doi: 10.1016/s0140-6736(89)90054-8. [DOI] [PubMed] [Google Scholar]
  5. Delmas P. D., Dupuis J., Duboeuf F., Chapuy M. C., Meunier P. J. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Miner Res. 1990 Mar;5 (Suppl 1):S143–S147. doi: 10.1002/jbmr.5650051322. [DOI] [PubMed] [Google Scholar]
  6. Ekstrand J., Alván G., Boréus L. O., Norlin A. Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol. 1977 Dec 2;12(4):311–317. doi: 10.1007/BF00607432. [DOI] [PubMed] [Google Scholar]
  7. Farley J. R., Wergedal J. E., Baylink D. J. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science. 1983 Oct 21;222(4621):330–332. doi: 10.1126/science.6623079. [DOI] [PubMed] [Google Scholar]
  8. Farley S. M., Wergedal J. E., Smith L. C., Lundy M. W., Farley J. R., Baylink D. J. Fluoride therapy for osteoporosis: characterization of the skeletal response by serial measurements of serum alkaline phosphatase activity. Metabolism. 1987 Mar;36(3):211–218. doi: 10.1016/0026-0495(87)90178-8. [DOI] [PubMed] [Google Scholar]
  9. Heaney R. P., Baylink D. J., Johnston C. C., Jr, Melton L. J., 3rd, Meunier P. J., Murray T. M., Nagant de Deuxchaisnes C. Fluoride therapy for the vertebral crush fracture syndrome. A status report. Ann Intern Med. 1989 Oct 15;111(8):678–680. doi: 10.7326/0003-4819-111-8-678. [DOI] [PubMed] [Google Scholar]
  10. LEONE N. C., STEVENSON C. A., HILBISH T. F., SOSMAN M. C. A roentgenologic study of a human population exposed to high-fluoride domestic water; a ten-year study. Am J Roentgenol Radium Ther Nucl Med. 1955 Nov;74(5):874–885. [PubMed] [Google Scholar]
  11. Mamelle N., Meunier P. J., Dusan R., Guillaume M., Martin J. L., Gaucher A., Prost A., Zeigler G., Netter P. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet. 1988 Aug 13;2(8607):361–365. doi: 10.1016/s0140-6736(88)92834-6. [DOI] [PubMed] [Google Scholar]
  12. Melkko J., Niemi S., Risteli L., Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 1990 Jul;36(7):1328–1332. [PubMed] [Google Scholar]
  13. O'Duffy J. D., Wahner H. W., O'Fallon W. M., Johnson K. A., Muhs J. M., Beabout J. W., Hodgson S. F., Riggs B. L. Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients. Am J Med. 1986 Apr;80(4):561–566. doi: 10.1016/0002-9343(86)90808-9. [DOI] [PubMed] [Google Scholar]
  15. Pak C. Y., Sakhaee K., Gallagher C., Parcel C., Peterson R., Zerwekh J. E., Lemke M., Britton F., Hsu M. C., Adams B. Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis. J Bone Miner Res. 1986 Dec;1(6):563–571. doi: 10.1002/jbmr.5650010611. [DOI] [PubMed] [Google Scholar]
  16. Riggins R. S., Zeman F., Moon D. The effects of sodium fluoride on bone breaking strength. Calcif Tissue Res. 1974 May 28;14(4):283–289. doi: 10.1007/BF02060302. [DOI] [PubMed] [Google Scholar]
  17. Riggs B. L., Hodgson S. F., O'Fallon W. M., Chao E. Y., Wahner H. W., Muhs J. M., Cedel S. L., Melton L. J., 3rd Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990 Mar 22;322(12):802–809. doi: 10.1056/NEJM199003223221203. [DOI] [PubMed] [Google Scholar]
  18. SINGH A., JOLLY S. S., BANSAL B. C., MATHUR C. C. Endemic fluorosis. Epidemiological, clinical and biochemical study of chronic fluorine intoxication in Panjab (India). Medicine (Baltimore) 1963 May;42:229–246. [PubMed] [Google Scholar]
  19. Simonen O., Laitinen O. Does fluoridation of drinking-water prevent bone fragility and osteoporosis? Lancet. 1985 Aug 24;2(8452):432–434. doi: 10.1016/s0140-6736(85)92748-5. [DOI] [PubMed] [Google Scholar]
  20. Smith R. Osteoporosis after 60. BMJ. 1990 Sep 8;301(6750):452–453. doi: 10.1136/bmj.301.6750.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Spak C. J., Sjöstedt S., Eleborg L., Veress B., Perbeck L., Ekstrand J. Tissue response of gastric mucosa after ingestion of fluoride. BMJ. 1989 Jun 24;298(6689):1686–1687. doi: 10.1136/bmj.298.6689.1686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Storm T., Thamsborg G., Steiniche T., Genant H. K., Sørensen O. H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990 May 3;322(18):1265–1271. doi: 10.1056/NEJM199005033221803. [DOI] [PubMed] [Google Scholar]
  23. Taves D. R. New approach to the treatment of bone disease with fluoride. Fed Proc. 1970 May-Jun;29(3):1185–1187. [PubMed] [Google Scholar]
  24. Watts N. B., Harris S. T., Genant H. K., Wasnich R. D., Miller P. D., Jackson R. D., Licata A. A., Ross P., Woodson G. C., 3rd, Yanover M. J. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990 Jul 12;323(2):73–79. doi: 10.1056/NEJM199007123230201. [DOI] [PubMed] [Google Scholar]
  25. Whitford G. M., Pashley D. H. Fluoride absorption: the influence of gastric acidity. Calcif Tissue Int. 1984 May;36(3):302–307. doi: 10.1007/BF02405334. [DOI] [PubMed] [Google Scholar]
  26. van Kesteren R. G., Duursma S. A., Visser W. J., van der Sluys Veer J., Backer Dirks O. Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium and vitamin D. Metab Bone Dis Relat Res. 1982;4(1):31–37. doi: 10.1016/0221-8747(82)90006-6. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES